CLDF Title
Contact Us | Bookmark
Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
  Liver News - REUTERS   Congress Calendar   Physician Resources  
DOACs better choice for Asian patients with AF and liver disease
Epigenetic events can promote liver regeneration in mice
Weight loss support helps people with fatty liver disease
Study shows major real-world impact of cervical cancer vaccines
Vets with PTSD at increased risk of death from suicide, accidents
Liver donation for transplant misunderstood, underutilized
VBI hepatitis B vaccine meets main goals in late-stage trial
Levels of liver fat biomarker tied to metabolic benefits of exercise
Early TIPS improves outcomes in cirrhosis with variceal bleeding
'Liquid biopsy' for pediatric fatty liver disease on the horizon
Laparoscopic on par with open surgery for colorectal-cancer liver metastases
Vedolizumab likely unhelpful for extra-intestinal manifestations of IBD
New therapy improves survival in hepatoma with portal-vein invasion
Cirrhosis, cancer risks higher with NAFLD- especially in diabetics
View Complete News Library
September 5-7, 2019
GHAPP - Gastroenterology & Hepatology Advanced Practice Providers
Las Vegas, NV, USA
October 2-6, 2019
IDSA - Infectious Diseases Society of America- ID Week
Washington, DC, USA
October 19-23, 2019
AATOD - American Association for the Treatment of Opioid Dependence
Orlando, FL, USA
October 19-23, 2019
UEGW - United European Gastroenterology Week
Barcelona, Spain
October 25-30, 2019
ACG - American College of Gastroenterology
San Antonio, TX, USA
October 24-26, 2019
NCAD - National Conference on Addiction Disorders- NCAD WEST
Denver, CO, USA
November 5-7, 2019
Obesity Week - American Society for Metabolic and Bariatric Surgery
Las Vegas, NV, USA
November 8-12, 2019
AASLD - American Association for the Study of Liver Diseases
Boston, MA, USA
January 13-14, 2020
PHC - Paris Hepatology Conference
Paris, France
March 4-8, 2020
APASL - Asian Pacific Association for the Study of Liver
Bali, Indonesia
April 15-19, 2020
EASL - European Association for the Study of the Liver
London, England
View all Congresses
  Featured Abstracts          
Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis
Hepatitis B and C virus infection as a risk factor for Parkinson
Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation
Maintaining complete virological suppression by reduced doses of nucleos(t)ide analogue in patients with chronic hepatitis B
Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston
Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting
Health implications of sex trading characteristics in Long Beach, California, USA
Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2
HIV and HCV screening among trauma patients
Renal Failure in Patients with Liver Cirrhosis: Novel Classifications, Biomarkers, Treatment
Hepatorenal Syndrome: Physiology, Diagnosis and Management
Renal Function in Cirrhosis: A Critical Review of Available Tools
Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome
Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis
Countdown to 2030: eliminating hepatitis B disease, China
A global scientific strategy to cure hepatitis B
Hepatitis B Virus and HIV Coinfection: Fibrosis, Fat, and Future Directions
Treatment of Viral Infections During Pregnancy
Novel Serum Biomarkers for Noninvasive Diagnosis and Screening of Nonalcoholic Fatty Liver Disease-Related Hepatic Fibrosis
Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy
Gender disparity in HCC: Is it the fat and not the sex?
Lenvatinib: A Review in Hepatocellular Carcinoma
Hepatitis C in pregnant American Indian and Alaska native women; 2003-2015
Hepatitis C Virus Treatment with Directly Acting Agents Reduces the Risk of Incident Diabetes - Results from ERCHIVES
Drug-Drug Interaction Studies of Methadone and Antiviral Drugs: Lessons Learned
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection and Psychiatric Disorders: An Integrated Analysis
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials
A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver Disease
Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease
Prevalence of non-alcoholic fatty liver disease on computed tomography in patients with inflammatory bowel disease visiting an emergency department
Past, present and future perspectives in nonalcoholic fatty liver disease
Biology of portal hypertension
Well Preserved Renal Function in Children With Untreated Chronic Liver Disease
Hepatorenal syndrome: the clinical impact of vasoactive therapy
The emergency medicine evaluation and management of the patient with cirrhosis
Favorable Response of Metastatic Hepatocellular Carcinoma to Treatment with Trans-arterial Radioembolization Followed by Sorafenib and Nivolumab
Management Approaches to Hepatitis B Virus Vaccination Nonresponse
Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis
Liver Fibrosis Determination
Quantitative evaluation of an integrated nurse model of care providing hepatitis Ctreatment to people attending homeless services in Melbourne, Australia
Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study
Life projects: the transformative potential of direct-acting antiviral treatment for hepatitis C among people who inject drugs
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study
Coffee consumption by type and risk of digestive cancer: a large prospective cohort study
Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents
Long-Term Impact of Direct-Acting Antiviral Agent Therapy in HCV Cirrhosis: Critical Review
Insurance status impacts treatment for hepatocellular carcinoma
A prospective study of nut consumption and risk of primary hepatocellular carcinoma in the U.S. women and men
The burden of illness of hepatorenal syndrome (HRS) in the United States: a retrospective analysis of electronic health records
Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome
Acute kidney injury in cirrhosis: implications for liver transplantation
Outcomes of renal dysfunction in patients with acute liver failure
Effect of Renal Diagnosis on Survival in Simultaneous Liver-Kidney Transplantation
Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample
L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy
How to Design a Multicenter Clinical Trial in Hepatic Encephalopathy
Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis
          View All Abstracts  
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Hepatorenal Syndrome
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
CLDF Sponsors & Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
CLDF Follow Us
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.